Praxis Precision Medicines Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-303.3M | $-182.8M | $-123.3M | $-214.0M | $-167.1M | $-61.8M | $-35.5M |
| Depreciation & Amortization | — | — | — | — | — | — | — |
| Depreciation | $140.0K | $358.0K | $432.0K | $419.0K | $182.0K | $50.0K | $37.0K |
| Amortization | — | — | — | — | — | — | — |
| Stock-Based Compensation | $33.9M | $41.4M | $24.9M | $28.6M | $22.7M | $5.2M | $668.0K |
| Net Cash from Operating Activities | $-249.1M | $-131.8M | $-111.1M | $-185.0M | $-124.6M | $-52.6M | $-33.4M |
| Investing Activities | |||||||
| Capital Expenditures | $56.0K | $0 | $50.0K | $444.0K | $1.1M | $0 | $103.0K |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-311.1M | $-248.5M | $39.0M | $96.9M | $-140.5M | $0 | $-103.0K |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $702.2M | $514.3M | $91.9M | $10.5M | $107.6M | $304.4M | $60.4M |
| Net Change in Cash | $142.0M | $134.1M | $19.7M | $-77.7M | $-157.5M | $251.8M | $26.9M |
| Free Cash Flow | $-249.1M | $-131.8M | $-111.2M | $-185.5M | $-125.6M | $-52.6M | $-33.5M |